New hope for Hard-to-Treat myeloma: Three-Drug combo enters early trial
Disease control
Recruiting now
This early-phase study tests a combination of three drugs (elotuzumab, CC-92480, and dexamethasone) in adults with multiple myeloma that has come back or stopped responding after prior treatments, including CD38 and BCMA therapies. The main goals are to find the safest dose and c…
Phase: PHASE1 • Sponsor: Abdullah Khan • Aim: Disease control
Last updated May 03, 2026 21:44 UTC